Furlong C - Search Results

1

Paraoxonase polymorphisms, haplotypes, and enzyme activity in Latino mothers and newborns.

Holland N, Furlong C, Bastaki M, Richter R, Bradman A, Huen K, Beckman K, Eskenazi B. Holland N, et al. Among authors: furlong c. Environ Health Perspect. 2006 Jul;114(7):985-91. doi: 10.1289/ehp.8540. Environ Health Perspect. 2006. PMID: 16835048 Free PMC article.

2

Validation of PON1 enzyme activity assays for longitudinal studies.

Huen K, Richter R, Furlong C, Eskenazi B, Holland N. Huen K, et al. Among authors: furlong c. Clin Chim Acta. 2009 Apr;402(1-2):67-74. doi: 10.1016/j.cca.2008.12.019. Epub 2008 Dec 24. Clin Chim Acta. 2009. PMID: 19146843 Free PMC article.

3

Association of in utero organophosphate pesticide exposure and fetal growth and length of gestation in an agricultural population.

Eskenazi B, Harley K, Bradman A, Weltzien E, Jewell NP, Barr DB, Furlong CE, Holland NT. Eskenazi B, et al. Environ Health Perspect. 2004 Jul;112(10):1116-24. doi: 10.1289/ehp.6789. Environ Health Perspect. 2004. PMID: 15238287 Free PMC article.

4

PON1 status of farmworker mothers and children as a predictor of organophosphate sensitivity.

Furlong CE, Holland N, Richter RJ, Bradman A, Ho A, Eskenazi B. Furlong CE, et al. Pharmacogenet Genomics. 2006 Mar;16(3):183-90. doi: 10.1097/01.fpc.0000189796.21770.d3. Pharmacogenet Genomics. 2006. PMID: 16495777

5

Association between in utero organophosphate pesticide exposure and abnormal reflexes in neonates.

Young JG, Eskenazi B, Gladstone EA, Bradman A, Pedersen L, Johnson C, Barr DB, Furlong CE, Holland NT. Young JG, et al. Among authors: furlong ce. Neurotoxicology. 2005 Mar;26(2):199-209. doi: 10.1016/j.neuro.2004.10.004. Neurotoxicology. 2005. PMID: 15713341

6

Paraoxonase (PON 1) as a biomarker of susceptibility for organophosphate toxicity.

Costa LG, Richter RJ, Li WF, Cole T, Guizzetti M, Furlong CE. Costa LG, et al. Biomarkers. 2003 Jan-Feb;8(1):1-12. doi: 10.1080/13547500210148315. Biomarkers. 2003. PMID: 12519632 Review.

7

Paraoxonase-1 (PON1) Status Analysis Using Non-Organophosphate Substrates.

Marsillach J, Richter RJ, Costa LG, Furlong CE. Marsillach J, et al. Curr Protoc. 2021 Jan;1(1):e25. doi: 10.1002/cpz1.25. Curr Protoc. 2021. PMID: 33484495 Free PMC article.

8

Determination of paraoxonase (PON1) status requires more than genotyping.

Richter RJ, Furlong CE. Richter RJ, et al. Among authors: furlong ce. Pharmacogenetics. 1999 Dec;9(6):745-53. Pharmacogenetics. 1999. PMID: 10634137

9

Paraoxonase 1 (PON1) status and substrate hydrolysis.

Richter RJ, Jarvik GP, Furlong CE. Richter RJ, et al. Toxicol Appl Pharmacol. 2009 Feb 15;235(1):1-9. doi: 10.1016/j.taap.2008.11.001. Epub 2008 Nov 13. Toxicol Appl Pharmacol. 2009. PMID: 19071155 Free PMC article.

10

Paraoxonase 1 status as a risk factor for disease or exposure.

Richter RJ, Jarvik GP, Furlong CE. Richter RJ, et al. Adv Exp Med Biol. 2010;660:29-35. doi: 10.1007/978-1-60761-350-3_4. Adv Exp Med Biol. 2010. PMID: 20221868 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

243 results

Search Page

Filters